Latest News
Global investment bank GCA Altium has advised the shareholders of Retrogenix, an early-stage contract research organisation (CRO) providing specialised bioanalytical services, on its sale to US-headquartered Charles River Laboratories.
Founded in 2008, Derbyshire-based Retrogenix offers cell microarray services for target receptor identification, off-target profiling, and target deconvolution on a wide range of novel therapeutics including biologics, cell therapies and small molecules. It provides the only commercially available platform for off-target screening for pre-clinical safety assurance in CAR T and other cell therapies.
Leveraging one of the world’s largest protein libraries which it has developed over the last ten years,
Align Capital Partners (ACP) has completed the majority recapitalisation of Custom Veterinary Services (CVS), a custom formulator and contract manufacturer exclusively focused on the animal health industry.
The Company’s FDA-registered facility in Miami, Florida produces nutritional supplements, dermatological, and grooming products for companion animals.
Founded by Ruben Martinez in 2005, CVS serves customers ranging from well-established animal health organisations to prospering e-commerce-focused brands. Under Ruben’s leadership, the Company has partnered with over 100 clients to date; working with them to identify their product needs, develop formulations, establish packaging, and scale up to production.
“CVS’ commitment is to produce
In this webinar, produced in conjunction with FIS, we look at how digitisation has changed the way PE groups approach sourcing capital in the global marketplace. REPLAY NOW
Tokoro Capital, a next generation real estate investment manager set up by Sanjay Sethi and Max Bassadone, has secured a new long term letting to Banque Palatine, one of France’s oldest banks, for the whole of its newly refurbished 86 Rue De Courcelles Grade-A office building in the iconic 8th Arrondissement of Paris.
Tokoro acquired the property vacant in December 2020, confident that, despite the pandemic, there was still strong demand for well located, modern office space which meets occupiers’ focus on health and wellbeing.
Banque Palatine, which was founded in 1780 in Lyon and which offers retail and
Partners Group, a global private markets firm, has agreed to sell its joint lead ownership stake in GlobalLogic, a specialist in digital engineering services, to Japanese conglomerate Hitachi LTD (Hitachi), on behalf of clients.
The transaction values GlobalLogic at an enterprise value of USD9.5 billion.
In 2018, Partners Group acquired a joint lead ownership equity stake in GlobalLogic alongside equity partner Canada Pension Plan Investment Board (CPP Investments) at an enterprise value of USD 2 billion. Partners Group and CPP Investments each hold an equity ownership interest of approximately 45 per cent in the business and will both be exiting
Kartesia, a European specialist provider of capital solutions for small and mid-sized companies, has held the final closing its inaugural senior debt fund, Kartesia Senior Opportunities (KSO) I at EUR1 billion.
The Senior Opportunities strategy provides senior financing solutions to European small and medium-sized companies with strong credit profiles and now has on-the-ground representation in all of Kartesia’s key markets – Spain, France, the DACH region, the Benelux and the UK.
Since it started investing, the fund has already made 16 investments, where Kartesia’s strong sourcing and execution capabilities have allowed for a swift deployment of capital. Recent transactions
JAB has promoted Joachim Creus and David Bell to the newly created position of Senior Partner, effective immediately.
Both Bell and Creus will continue to report to Managing Partner and CEO Olivier Goudet, supporting both him and Managing Partner and Chairman Peter Harf. These promotions are another milestone in JAB’s continued focus on building and expanding the firm to position it for long-term growth.
Creus has been with JAB for over 10 years and has played a critical role in building it into a global investment company. He has been at the cetre of JAB’s major investments and expansion
Vinci Partners Investments, the controlling company of an alternative investment platform in Brazil, has held the final closing of Vinci Impacto e Retorno IV (VIR IV), the impact family of funds managed by the Vinci Partners’ Private Equity segment.
The fund was formally closed at the Hard Cap of BRL1 billion.
This fundraise represents additional long-term capital with formal lock ups of at least 10 years, raised through local and offshore institutional clients, high net-worth individuals, and retail investors.
VIR IV has a unique strategy in Brazil, with a dual mandate to generate favourable market returns as well as impact,
Manchester-based corporate advisory firm Rickitt Mitchell is investing in its team with the promotion of Charlotte Greenhalgh to Manager.
The news follows the recent promotion of Kaine Smith to the board, with further hires in the pipeline.
Greenhalgh started her career at PwC where she completed her ACA qualifications, before joining Rickitt Mitchell in 2019 as a Corporate Finance Executive. Since then, she has progressed quickly, supporting on a number of high-profile transactions with a combined value of over GBP100 million. Most recently, Greenhalgh has worked with board members Neil Mitchell and Kaine Smith on the sale of Antler
Cerba HealthCare (Cerba HealthCare), together with Partners Group, a global private markets firm, and the Public Sector Pension Investment Board (PSP Investments), one of Canada’s largest pension investment managers, has entered into exclusive discussions with the EQT IX fund (EQT Private Equity) to enable the Company to continue its long-term innovation services strategy and enhance services for patients and the medical community.
Cerba HealthCare, headquartered in France and firmly established in Europe and Africa through its historical routine and specialty biology expertise, also operates globally through its clinical trials business unit for the validation of new compounds and vaccines. The
Special Reports
Featured
- Insight
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
